Deutsche Märkte geschlossen

AbbVie Inc. (ABBV)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
112,37+0,19 (+0,17%)
Ab 2:35PM EST. Markt geöffnet.

AbbVie Inc.

1 North Waukegan Road
North Chicago, IL 60064
United States
847 932 7900
http://www.abbvie.com

Sektor(en)Healthcare
BrancheDrug Manufacturers—General
Vollzeitmitarbeiter47.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Richard A. GonzalezChairman & CEO7,11MN/A1954
Dr. Michael E. SeverinoVice Chairman & Pres3,98MN/A1966
Mr. Robert A. MichaelExec. VP & CFO2,76MN/A1970
Ms. Laura J. SchumacherVice Chairman of External Affairs, Chief Legal Officer & Corp. Sec.4,3MN/A1963
Mr. Carlos AlbanVice Chairman & Chief Commercial Officer4,08MN/A1963
Dr. Azita Saleki-GerhardtExec. VP of OperationsN/AN/A1963
Dr. Thomas J. HudsonSr. VP of R&D and Chief Scientific OfficerN/AN/A1962
Ms. Elizabeth SheaVP of Investor RelationsN/AN/AN/A
Mr. Timothy J. RichmondExec. VP & Chief HR OfficerN/AN/A1966
Mr. Scott C. Brun M.D.VP of Scientific Affairs & Head of AbbVie VenturesN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2019 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Frontier Medicines, Corp.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Corporate Governance

AbbVie Inc.s ISS Governance QualityScore, Stand 1. Dezember 2020, lautet 8. Die grundlegenden Scores sind Audit: 2, Vorstand: 7, Shareholderrechte: 9, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.